TradingView
AlenCiken
Aug 5, 2020 10:55 AM
U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial
OTC:RVVTF
60
Revive Therapeutics Ltd.
OTC
Description
⋅
Aug 5, 2020 10:55 AM
UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19
globenewswire.com/news-release/2020/07/31/2071193/0/en/UPDATE-Revive-Therapeutics-Announces-U-S-FDA-Approval-of-Confirmatory-Phase-3-Clinical-Trial-for-Bucillamine-in-COVID-19.html
Fundamental Analysis
Trend Analysis
Chart Patterns
Comments
day0
⋅
May 26, 2021 11:08 PM
Perhaps, $0.93 by 2022-03-31 if the current monthly trend continues.
More